<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01798186</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00082269</org_study_id>
    <nct_id>NCT01798186</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation</brief_title>
  <official_title>Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Substance Abuse and Mental Health Services Administration (SAMHSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>RTI International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This primary aim of this study is to assess the effects of passive (second-hand) inhalation
      of cannabis smoke on toxicological analysis of &quot;native&quot; oral fluid (saliva), urine and blood
      specimens. The results of this study will help inform the validity of oral fluid as a
      biomarker of cannabis exposure and to determine whether, and for how long, passive inhalation
      of cannabis smoke could result in a positive toxicology result.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Between subjects Phase I study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants are blind to the THC concentrations of cannabis being administered</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Delta-9-tetrahydrocannabinol (THC) Cmax in Blood</measure>
    <time_frame>0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 22, 26, 30, and 34 hours post cannabis exposure</time_frame>
    <description>After exposure to cannabis, we will conduct a pharmacokinetic analysis of THC in blood collected.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delta-9-tetrahydrocannabinol (THC) Cmax in Oral Fluid</measure>
    <time_frame>Samples collected 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 22, 26, 30, and 34 hours post cannabis exposure</time_frame>
    <description>After exposure to cannabis, we will conduct a pharmacokinetic analysis of THC in oral fluid.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective VAS Drug Effect</measure>
    <time_frame>immediately post cannabis exposure.</time_frame>
    <description>Visual analog scale (0-100; not at all to extremely) of subjective &quot;Drug Effect&quot;</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Cannabis Toxicology</condition>
  <arm_group>
    <arm_group_label>Cannabis 5% THC, No Ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this condition will be passively exposed to second-hand cannabis smoke from cannabis containing 5% THC and in a room with no ventilation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabis 11% THC, No Ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this condition will be passively exposed to second-hand cannabis smoke from cannabis containing 11% THC and in a room with no ventilation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabis 11% THC, Ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this condition will be passively exposed to second-hand cannabis smoke from cannabis containing 11% THC in a room with active ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cannabis</intervention_name>
    <description>Participants will be exposed to cannabis smoke present in ambient air</description>
    <arm_group_label>Cannabis 5% THC, No Ventilation</arm_group_label>
    <arm_group_label>Cannabis 11% THC, No Ventilation</arm_group_label>
    <arm_group_label>Cannabis 11% THC, Ventilation</arm_group_label>
    <other_name>Marijuana</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Participants must:

          -  Be between the ages of 18 and 45

          -  Be in good general health based on a physical examination, medical history, vital
             signs, 12-lead ECG and screening urine and blood tests

          -  Demonstrate ability to expectorate 3-5 mL of &quot;native&quot; oral fluid over a 5-minute
             period

          -  Be willing and able to abstain from use of any over-the-counter (OTC) or prescription
             drugs (other than birth control medications) after providing written informed consent
             and continuing until discharged from the study. OTC antacids may be taken up to 12
             hours prior to dosing

          -  Not be pregnant or nursing (if female), and using effective birth control. All females
             must have a negative serum pregnancy test at the Screening Visit and a negative urine
             pregnancy test at clinic admission.

          -  Have a body mass index (BMI) in the range of 19 to 33 kg/m2

          -  Have head hair that is at least 4-6 cm (approximately two inches) in length on the
             back of the head.

          -  Blood pressure at Screening Visit must not exceed a systolic blood pressure (SBP) of
             140 mmHg or a diastolic blood pressure (DBP) of 90 mmHg

          -  Must not have history of significant medical or psychiatric illness judged by the
             investigator to put the participant at greater risk of experiencing an adverse event
             due to exposure or completion of other study procedures.

          -  Cannot have been enrolled in another clinical trial or have received any drug as part
             of a research study within 30 days prior to dosing.

          -  No history of panic/anxiety reaction to extended periods of confinement in close
             quarters, smoke filled areas, or tight social situations.

          -  No history of adverse reactions to cannabis exposure, whether via direct use or
             passive exposure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins Behavioral Pharmacology Research Unit</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2013</study_first_posted>
  <results_first_submitted>April 17, 2017</results_first_submitted>
  <results_first_submitted_qc>August 2, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 3, 2017</results_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Participants were randomized to 3 experimental sessions. Additionally, participants were recruited to smoke cannabis in order to generate the smoke that was passively inhaled by the experimental groups.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cannabis 5% THC, no Ventilation</title>
          <description>passive exposure to 5% THC in an unventilated room</description>
        </group>
        <group group_id="P2">
          <title>Cannabis 11% THC, no Ventilation</title>
          <description>passive exposure to 11% THC cannabis smoke in an unventilated room</description>
        </group>
        <group group_id="P3">
          <title>Cannabis 11% THC, Ventilated</title>
          <description>passive exposure to 11% THC cannabis smoke in a room with active air ventilation</description>
        </group>
        <group group_id="P4">
          <title>Active Smokers</title>
          <description>Participants that smoked cannabis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cannabis 5% THC, no Vent</title>
          <description>passive exposure to 5% THC cannabis smoke, unventilated room</description>
        </group>
        <group group_id="B2">
          <title>Cannabis 11% THC, no Vent</title>
          <description>passive exposure to 11% THC cannabis smoke, unventilated room</description>
        </group>
        <group group_id="B3">
          <title>Cannabis 11% THC, Vent</title>
          <description>passive exposure to 11% THC cannabis smoke, ventilated room</description>
        </group>
        <group group_id="B4">
          <title>Smokers</title>
          <description>cannabis smokers</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="6"/>
            <count group_id="B4" value="8"/>
            <count group_id="B5" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" spread="3"/>
                    <measurement group_id="B2" value="29" spread="9"/>
                    <measurement group_id="B3" value="30" spread="8"/>
                    <measurement group_id="B4" value="29" spread="6"/>
                    <measurement group_id="B5" value="28" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Delta-9-tetrahydrocannabinol (THC) Cmax in Blood</title>
        <description>After exposure to cannabis, we will conduct a pharmacokinetic analysis of THC in blood collected.</description>
        <time_frame>0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 22, 26, 30, and 34 hours post cannabis exposure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5% THC Cannabis, no Vent</title>
            <description>passive exposure to 5%THC cannabis smoke in unventilated room</description>
          </group>
          <group group_id="O2">
            <title>11% THC Cannabis Smoke, no Vent</title>
            <description>passive exposure to 11% THC cannabis smoke in unventilated room</description>
          </group>
          <group group_id="O3">
            <title>11% THC Cannabis, Vent</title>
            <description>passive exposure to 11% THC cannabis smoke in ventilated room</description>
          </group>
        </group_list>
        <measure>
          <title>Delta-9-tetrahydrocannabinol (THC) Cmax in Blood</title>
          <description>After exposure to cannabis, we will conduct a pharmacokinetic analysis of THC in blood collected.</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.5"/>
                    <measurement group_id="O2" value="3.07" spread="1.6"/>
                    <measurement group_id="O3" value="0.5" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Delta-9-tetrahydrocannabinol (THC) Cmax in Oral Fluid</title>
        <description>After exposure to cannabis, we will conduct a pharmacokinetic analysis of THC in oral fluid.</description>
        <time_frame>Samples collected 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 22, 26, 30, and 34 hours post cannabis exposure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5%THC Cannabis, no Ventilation</title>
            <description>passive exposure to 5% THC cannabis smoke, no room ventilation</description>
          </group>
          <group group_id="O2">
            <title>11%THC Cannabis, no Ventilation</title>
            <description>passive exposure to 11% THC cannabis smoke, no room ventilation</description>
          </group>
          <group group_id="O3">
            <title>11% THC Cannabis, no Ventilation</title>
            <description>passive exposure to 5% THC cannabis smoke, with active room ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Delta-9-tetrahydrocannabinol (THC) Cmax in Oral Fluid</title>
          <description>After exposure to cannabis, we will conduct a pharmacokinetic analysis of THC in oral fluid.</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="5" upper_limit="86"/>
                    <measurement group_id="O2" value="82" lower_limit="12" upper_limit="308"/>
                    <measurement group_id="O3" value="17" lower_limit="2" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective VAS Drug Effect</title>
        <description>Visual analog scale (0-100; not at all to extremely) of subjective &quot;Drug Effect&quot;</description>
        <time_frame>immediately post cannabis exposure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5%THC, no Vent</title>
            <description>passive 5% THC cannabis smoke, no room ventilation</description>
          </group>
          <group group_id="O2">
            <title>11% THC Cannabis Smoke, no Vent</title>
            <description>passive exposure to 11% THC cannabis smoke in unventilated room</description>
          </group>
          <group group_id="O3">
            <title>11% THC Cannabis, Ventilated</title>
            <description>passive exposure to 11% THC cannabis smoke in ventilated room</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective VAS Drug Effect</title>
          <description>Visual analog scale (0-100; not at all to extremely) of subjective &quot;Drug Effect&quot;</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="5"/>
                    <measurement group_id="O2" value="23" spread="13"/>
                    <measurement group_id="O3" value="3" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>5% THC Cannabis Smoke, no Ventilation</title>
          <description>passive exposure to 5%THC cannabis smoke in unventilated room</description>
        </group>
        <group group_id="E2">
          <title>11% THC Cannabis Smoke, no Ventilation</title>
          <description>passive exposure to 11%THC cannabis smoke in unventilated room</description>
        </group>
        <group group_id="E3">
          <title>11% THC Cannabis Smoke, Ventilation</title>
          <description>passive exposure to 11%THC cannabis smoke in ventilated room</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ryan Vandrey</name_or_title>
      <organization>Johns Hopkins University</organization>
      <phone>410-550-4036</phone>
      <email>rvandrey@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

